Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study (Q42999353)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2000

Language	Label	Description	Also known as
English	Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study	scientific article published in August 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

author name string

Grant PR

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Black A

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Garcia N

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Garson JA

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

439-442

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Glutathione deficiency and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Identifiers

10.1002/1096-9071(200008)61:4<439::AID-JMV5>3.0.CO;2-L

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42999353&oldid=2229432991"